openPR Logo
Press release

Abdominal Aortic Aneurysm Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic

05-21-2024 09:09 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Abdominal Aortic Aneurysm Pipeline and Clinical Trials

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Abdominal Aortic Aneurysm pipeline constitutes key companies continuously working towards developing Abdominal Aortic Aneurysm treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.

"Abdominal Aortic Aneurysm Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Abdominal Aortic Aneurysm Market.

The Abdominal Aortic Aneurysm Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.

Some of the key takeaways from the Abdominal Aortic Aneurysm Pipeline Report: https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
• Companies across the globe are diligently working toward developing novel Abdominal Aortic Aneurysm treatment therapies with a considerable amount of success over the years. Abdominal Aortic Aneurysm Key players such as - Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic, MicroPort Scientific Corporation, Artivion, Inc., Lifetech Scientific (Shenzhen) Co., Ltd., Lombard Medical, Endologix LLC, Latecba SA, Nectero Medical, Cardiatis, SA, Hangzhou Endonom Medtech Co., Ltd., and others, and others, are developing therapies for the Abdominal Aortic Aneurysm treatment
• Abdominal Aortic Aneurysm Emerging therapies such as - Ticagrelor, Metformin Glucophage, Abdominal Aortic Aneurysm Stent Graft System, Fenestrated AlturaTM FEVAR Stent Graft, Seta Latecba Stent Grafts, Nectero EAST®, Bifurcated MFM®, and others, and others are expected to have a significant impact on the Abdominal Aortic Aneurysm market in the coming years.
• In January 2024, Arizona-based Nectro Medical has initiated a Phase II/III trial evaluating the safety and efficacy of its endovascular aneurysm stabilisation treatment (Nectero EAST). Nectero EAST is a single-use, endovascular system made up of a dual-balloon delivery catheter and stabiliser mixture of pentagalloyl glucose (PGG). The PGG, when administered locally, can bind to elastin and collagen to potentially strengthen the aortic wall. Animal studies have shown that PGG can hinder the development of abdominal aortic aneurysm (AAA).

Abdominal Aortic Aneurysm Overview
Abdominal Aortic Aneurysm (AAA) is a localized enlargement of the abdominal aorta such that the diameter is greater than 3 cm or more than 50% larger than usual. It occurs when atherosclerosis or plaque buildup causes the walls of the abdominal aorta to become weak and bulge outward like a balloon.

Get a Free Sample PDF Report to know more about Abdominal Aortic Aneurysm Pipeline Therapeutic Assessment-
https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Abdominal Aortic Aneurysm Pipeline Therapeutics Assessment
• Abdominal Aortic Aneurysm Assessment by Product Type
• Abdominal Aortic Aneurysm By Stage and Product Type
• Abdominal Aortic Aneurysm Assessment by Route of Administration
• Abdominal Aortic Aneurysm By Stage and Route of Administration
• Abdominal Aortic Aneurysm Assessment by Molecule Type
• Abdominal Aortic Aneurysm by Stage and Molecule Type

DelveInsight's Abdominal Aortic Aneurysm Report covers around products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration

Some of the key companies in the Abdominal Aortic Aneurysm Therapeutics Market include:
Key companies developing therapies for Abdominal Aortic Aneurysm treatment are - CARDIATIS S.A., CARDINAL HEALTH, INC., COOK MEDICAL, INC., ENDOLOGIX, INC., jotec gmbh, LOMBARD MEDICAL, INC., MEDTRONIC PLC, nano endoluminal sa, TERUMO CORPORATION, W. L. GORE & ASSOCIATES, INC., and others.

Download Sample PDF Report to know more about Abdominal Aortic Aneurysm drugs and therapies https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Emerging Abdominal Aortic Aneurysm Drugs and devices Under Different Phases of Clinical Development Include:
• Metformin Glucophage: Merck Serono
• Ticagrelor: AstraZeneca
• Abdominal Aortic Aneurysm Stent Graft System: Lifetech Scientific
• Fenestrated AlturaTM FEVAR Stent Graft: Lombard Medical
• Seta Latecba Stent Grafts: Latecba SA
• Nectero EAST®: Nectero Medical
• Bifurcated MFM®: Cardiatis

Abdominal Aortic Aneurysm Pipeline Analysis:
The Abdominal Aortic Aneurysm pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Abdominal Aortic Aneurysm with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Abdominal Aortic Aneurysm Treatment.
• Abdominal Aortic Aneurysm key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Abdominal Aortic Aneurysm Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Abdominal Aortic Aneurysm market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Further Abdominal Aortic Aneurysm product details are provided in the report. Download the Abdominal Aortic Aneurysm pipeline report to learn more about the emerging Abdominal Aortic Aneurysm therapies
https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Scope of Abdominal Aortic Aneurysm Pipeline Drug Insight
• Coverage: Global
• Key Abdominal Aortic Aneurysm Companies: Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic, MicroPort Scientific Corporation, Artivion, Inc., Lifetech Scientific (Shenzhen) Co., Ltd., Lombard Medical, Endologix LLC, Latecba SA, Nectero Medical, Cardiatis, SA, Hangzhou Endonom Medtech Co., Ltd., and others, and others
• Key Abdominal Aortic Aneurysm Therapies: Ticagrelor, Metformin Glucophage, Abdominal Aortic Aneurysm Stent Graft System, Fenestrated AlturaTM FEVAR Stent Graft, Seta Latecba Stent Grafts, Nectero EAST®, Bifurcated MFM®, and others, and others
• Abdominal Aortic Aneurysm Therapeutic Assessment: Abdominal Aortic Aneurysm current marketed and Abdominal Aortic Aneurysm emerging therapies
• Abdominal Aortic Aneurysm Market Dynamics: Abdominal Aortic Aneurysm market drivers and Abdominal Aortic Aneurysm market barriers

Request for Sample PDF Report for Abdominal Aortic Aneurysm Pipeline Assessment and clinical trials https://www.delveinsight.com/sample-request/abdominal-aortic-aneurysm-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Table of Contents
1 Abdominal Aortic Aneurysm Report Introduction
2 Abdominal Aortic Aneurysm Executive Summary
3 Abdominal Aortic Aneurysm Overview
4 Abdominal Aortic Aneurysm- Analytical Perspective In-depth Commercial Assessment
5 Abdominal Aortic Aneurysm Pipeline Therapeutics
6 Abdominal Aortic Aneurysm Late Stage Products (Phase II/III)
7 Abdominal Aortic Aneurysm Mid Stage Products (Phase II)
8 Abdominal Aortic Aneurysm Early Stage Products (Phase I)
9 Abdominal Aortic Aneurysm Preclinical Stage Products
10 Abdominal Aortic Aneurysm Therapeutics Assessment
11 Abdominal Aortic Aneurysm Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Abdominal Aortic Aneurysm Key Companies
14 Abdominal Aortic Aneurysm Key Products
15 Abdominal Aortic Aneurysm Unmet Needs
16 Abdominal Aortic Aneurysm Market Drivers and Barriers
17 Abdominal Aortic Aneurysm Future Perspectives and Conclusion
18 Abdominal Aortic Aneurysm Analyst Views
19 Appendix
20 About DelveInsight
*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Related Reports:

Abdominal Aortic Aneurysm Market https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Abdominal Aortic Aneurysm-Market Insights, Epidemiology, and Market Forecast-2032' report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),

Abdominal Aortic Aneurysm Epidemiology https://www.delveinsight.com/report-store/abdominal-aortic-aneurysm-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
DelveInsight's 'Abdominal Aortic Aneurysm Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Latest Report Offered By DelveInsight:

Surgical Robotic System Market https://www.delveinsight.com/report-store/surgical-robotic-system-market
Surgical Robotic Systems Market By Application (Urology, Gynecology, Neurosurgery, Orthopedics, And Others), By End User (Hospitals, Ambulatory Surgical Centers, And Others), And by geography is estimated to register appreciable CAGR forecast till 2028 owing to increase in surgical procedures and rising popularity of minimally invasive surgical interventions.

Cancer Diagnostics Market
https://www.delveinsight.com/report-store/cancer-diagnostic-market
Cancer Diagnostics Market By Type (Product Type [Reagent & Kits and Instruments], and Services), Technique (Molecular Diagnostics [Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescent In-Situ Hybridization (FISH), Microarray, and Immunohistochemistry], Diagnostics Imaging [Ultrasound & Radiology, Mammography, MRI Scan, CT Scan, and Nuclear Medicine Scans], Endoscopy, and Biopsy [Standard Biopsy and Liquid Biopsy]), Cancer Type (Breast Cancer, Colorectal Cancer, Lung Cancer, Prostate Cancer, and Others), End-User (Hospitals, Diagnostics Labs, and Others), and Geography, is expected to grow at a significant CAGR forecast till 2028 owing to the growing burden of cancer across the globe and rise in various product launches for efficient detection of cancer.

Ventilator Market
https://www.delveinsight.com/report-store/ventilators-market
Ventilators Market By Mobility (Intensive Care Ventilators, Portable/Transportable Ventilators), By Type (Adult/Pediatric Ventilators, Neonatal/Infant Ventilators), By Interface (Invasive Ventilation, Non-Invasive Ventilation), By End-User (Hospitals, Home Care, Ambulatory Surgical Centers, Others), By Geography is expected to grow at a steady CAGR forecast till 2028 owing to lauch of advanced devices and increasing prevalence of respiratory diseases such as COPD.

Zika Virus Market
https://www.delveinsight.com/report-store/zika-virus-market
DelveInsight's "Zika Virus Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Zika Virus, historical and forecasted epidemiology as well as the Zika Virus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Contact Us:
Gaurav Bora
gbora@delveinsight.com
+14699457679
www.delveinsight.com/consulting

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Abdominal Aortic Aneurysm Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Merck Serono, AstraZeneca, Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates, Inc., Medtronic here

News-ID: 3506776 • Views:

More Releases from DelveInsight Business Research

Anaplastic Thyroid Cancer Pipeline Dynamics 2024: FDA Approvals, Therapeutic Advances, and Clinical Trials Insights | Johnson and Johnson, Medtronic Plc, Merck KGaA, Novartis AG, Pfizer Inc., Akorn Inc., Amneal Pharmaceuticals Inc.
Anaplastic Thyroid Cancer Pipeline Dynamics 2024: FDA Approvals, Therapeutic Adv …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Anaplastic Thyroid Cancer pipeline constitutes 8+ key companies continuously working towards developing 8+ Anaplastic Thyroid Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Anaplastic Thyroid Cancer Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Anaplastic Thyroid
Parkinson's Disease Psychosis Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Treatment Market, Therapies, ROA, MOA and Key Companies by DelveInsight | Vanda Pharmaceuticals, Sumitomo Pharma, ACADIA Pharmaceuticals, Otsuka America Pharmaceutical,
Parkinson's Disease Psychosis Clinical Trials Analysis 2024: EMA, PDMA, FDA Appr …
(Albany, United States) As per DelveInsight's assessment, globally, the Parkinson's disease Psychosis Pipeline constitutes 5+ key companies continuously working towards developing 5+ Parkinson's Disease Psychosis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight. In the Parkinson's Disease Psychosis pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any),
Relapsed/Refractory Acute Myeloid Leukemia Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Foghorn Therapeutics, AB Science, Oncoceutics, Sanofi, TC Biopharm, Merck & Co, GlycoMimetics
Relapsed/Refractory Acute Myeloid Leukemia Pipeline 2024: Clinical Trials Assess …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Relapsed/Refractory Acute Myeloid Leukemia pipeline constitutes 50+ key companies continuously working towards developing 50+ Relapsed/Refractory Acute Myeloid Leukemia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Relapsed/Refractory Acute Myeloid Leukemia Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across
Oral Mucositis Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Pipeline, Therapies, Mechanism of Action, Route of Administration and Companies by DelveInsight
Oral Mucositis Clinical Trials Analysis 2024: EMA, PDMA, FDA Approvals, Pipeline …
(Albany, United States) As per DelveInsight's assessment, globally, the Oral Mucositis Pipeline constitutes 10+ key companies continuously working towards developing 10+ Oral Mucositis Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight. In the Oral Mucositis Pipeline Report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, Oral Mucositis NDA approvals (if any), and

All 5 Releases


More Releases for Abdominal

Global Abdominal Aortic Aneurysm Market Report Forecast to 2027
An inflated region in the lower section of the main conduit that delivers blood to the body is known as an abdominal aortic aneurysm (aorta). The aorta is a blood vessel that travels from your heart to your chest and belly. A burst abdominal aortic aneurysm can cause life-threatening haemorrhage since the aorta is the body's biggest blood artery. Treatment options range from cautious waiting to emergency surgery, depending on
Intra-abdominal Infections Market Estimated to Flourish by 2024
The intra-abdominal infection (IAI) indicates inflammation of a single organ in the entire intra-abdominal area or peritonitis (inflammation of the abdominal lining). Major IAIs include intra-abdominal abscess, appendicitis, diverticulitis, diarrhea, food poisoning, and infection by Helicobacter pylori. Diarrhea, abdominal pain, nausea, and fever are common symptoms of IAI. It is believed that inflammation of intra-abdominal organs is caused by pathogenic microorganisms. Intra-abdominal infections are predominantly polymicrobial in nature. These infections
Abdominal Wheels Market to Witness Robust Expansion by 2024
LP INFORMATION offers a latest published report on Abdominal Wheels Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. According to this study, over the next five years the Abdominal Wheels market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular,
Major Advancements Of Abdominal Surgical Robots Market 2018
Albany, NY, 8th January : Recent research and the current scenario as well as future market potential of "Abdominal Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021" globally. Market Research announces that it has published a new study Abdominal Surgical Robots: Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=483592 The 2015 study has 416 pages, 176 tables and figures.
Abdominal Obesity Treatment Market Technological breakthroughs 2025
Abdominal obesity or central obesity is medical condition in which excessive fat has built up around the abdomen and stomach to that it may have a negative impact on the human health. An individual is abdominally obese if the size of their waist is more than 90 cm in males and over 84 cm in females. It has been observed that unhealthy lifestyle practice and over consumption of fast foods
Intra-abdominal Infections Market Lucrative Technological breakthroughs 2025
The intra-abdominal infection (IAI) indicates inflammation of a single organ in the entire intra-abdominal area or peritonitis (inflammation of the abdominal lining). Major IAIs include intra-abdominal abscess, appendicitis, diverticulitis, diarrhea, food poisoning, and infection by Helicobacter pylori. Diarrhea, abdominal pain, nausea, and fever are common symptoms of IAI. It is believed that inflammation of intra-abdominal organs is caused by pathogenic microorganisms. Intra-abdominal infections are predominantly polymicrobial in nature. These infections